Mishell Kerr
Family · Norman, OKNPI 1023460318
Payments from drug & device makers
Across 129 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$615
- AstraZeneca$294
- Lilly USA, LLC$259
- Astellas Pharma US Inc$129
- Esperion Therapeutics, Inc.$84
- Idorsia Pharmaceuticals US Inc$81
- plus $764 from 19 others
Across 12 payments — averaging $132.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2K
What the payments were for
- Food & beverage$2,16197%
- Education$653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $615 |
| AstraZeneca | 16 | $294 |
| Lilly USA, LLC | 19 | $259 |
| Astellas Pharma US Inc | 4 | $129 |
| Esperion Therapeutics, Inc. | 5 | $84 |
| Idorsia Pharmaceuticals US Inc | 5 | $81 |
| GSK | 6 | $80 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Amgen | 4 | $56 |
| Novartis | 4 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $53 |
| Almatica Pharma LLC | 2 | $52 |
| Exact Sciences | 3 | $51 |
| Azurity Pharmaceuticals, Inc. | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Bayer | 2 | $35 |
| Dexcom, Inc. | 2 | $33 |
| Pfizer | 2 | $33 |
| Ascendis Pharma Endocrinology Inc | 1 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Organon | 2 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Cequr Corporation | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$116
How this compares
$2,226 in reported general payments places this provider in the 80th percentile of 2,026 family providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $587 |
| Valsartan | 12 | $433 |
| Gabapentin | 30 | $409 |
| Famotidine | 26 | $309 |
| Levothyroxine Sodium | 24 | $280 |
| Duloxetine Hcl | 18 | $259 |
| Nifedipine ErNifedipine | 11 | $256 |
| Metoprolol Succinate | 16 | $241 |
| Lisinopril | 11 | $186 |
| Meloxicam | 22 | $168 |
| Rosuvastatin Calcium | 19 | $121 |
| Alendronate Sodium | 18 | $107 |
| Methylprednisolone | 14 | $98 |
| Hydralazine Hcl | 34 | $93 |
| Cephalexin | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other family in Norman
- Brandy ReevesNorman$17K
- Katherine BuckNorman$14K
- Jackson LaizureNorman$13K
- Jordan HarrisNorman$12K
- Julie RobersonNorman$10K
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.